MAP2K7 and lung carcinoma: Our previous study [5] showed that the MEK inhibitor AZD6244 potently inhibited proliferation at nanomolar concentrations in Calu-6, H2347, and H3122 lung cancer cell lines but had little effect on H196, Calu-3, H522, or HCC2450 cell lines.